Unusual Aspects of Small Cell Carcinoma of the Ovary of Hypercalcaemic Type:

Gene of the month: TLE 1

(2021) Karen Pinto et al.   JOURNAL OF CLINICAL PATHOLOGY

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines

(2020) Marc Tischkowitz et al.   CLINICAL CANCER RESEARCH

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis

(2020) Aurélie Auguste et al.   Cells

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours

(2019) Catherine Genestie et al.   BRITISH JOURNAL OF CANCER

Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm

(2017) W Glenn McCluggage et al.   HISTOPATHOLOGY

Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type

(2016) Niamh Conlon et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type

(2016) Leora Witkowski et al.   GYNECOLOGIC ONCOLOGY

Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics

(2016) Blaise A Clarke et al.   HISTOPATHOLOGY

Recently characterized molecular events in uncommon gynaecological neoplasms and their clinical importance

(2016) Leora Witkowski et al.   HISTOPATHOLOGY

SMARCA4 (BRG1) Loss of Expression Is a Useful Marker for the Diagnosis of Ovarian Small Cell Carcinoma of the Hypercalcemic Type (Ovarian Rhabdoid Tumor)

(2015) Marie Karanian-Philippe et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

An Update on the Application of Newly Described Immunohistochemical Markers in Soft Tissue Pathology

(2015) George Lin et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

(2015) Anthony N Karnezis et al.   JOURNAL OF PATHOLOGY

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type

(2015) Petar Jelinic et al.   MODERN PATHOLOGY

Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4

(2014) Pilar Ramos et al.   NATURE GENETICS

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

(2014) Leora Witkowski et al.   NATURE GENETICS

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary

(2014) Petar Jelinic et al.   NATURE GENETICS

Ovarian small cell carcinoma of hypercalcemic type – evidence of germline origin and smarca4 gene inactivation. a pilot study

(2013) Jolanta Kupryjańczyk et al.   POLISH JOURNAL OF PATHOLOGY

TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): Analysis of 319 cases

(2010) Thomas Knösel et al.   EUROPEAN JOURNAL OF CANCER

Prospective Evaluation of TLE1 as a Diagnostic Immunohistochemical Marker in Synovial Sarcoma

(2009) Amanda Jagdis et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms

(2009) Kemal Kosemehmetoglu et al.   MODERN PATHOLOGY